Precision Neuroscience Funding: $180M Raised, Series C
Precision Neuroscience is a Biotech company based in New York City, Country. It has raised $180M in total funding. Latest round: Series C.
Precision Neuroscience funding overview
Precision Neuroscience is a Biotech company based in New York City, Country. Precision Neuroscience has raised $180M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in December 2024. The round record for Precision Neuroscience runs through 2024; nothing later has been disclosed. Investors on record include General Equity Holdings, B Capital, Duquesne Family Office, Steadview Capital, SCI Ventures, Stanley Druckenmiller's investment firm. 6 distinct backers are named across the disclosed rounds.
Precision Neuroscience at a glance
Total raised
$180M
Latest round
Series C
Latest round date
December 2024
Industry
Biotech
Headquarters
New York City, Country
Notable investors
General Equity Holdings, B Capital, Duquesne Family Office, Steadview Capital, SCI Ventures, Stanley Druckenmiller's investment firm
Frequently asked about Precision Neuroscience funding
How much has Precision Neuroscience raised?
Precision Neuroscience has raised $180M in total disclosed funding across the rounds on record.
Who has invested in Precision Neuroscience?
General Equity Holdings, B Capital, Duquesne Family Office, Steadview Capital, SCI Ventures, Stanley Druckenmiller's investment firm are named among the investors backing Precision Neuroscience.
What was the latest Precision Neuroscience funding round?
The most recent disclosed round is a Series C, announced in December 2024.
Where is Precision Neuroscience based?
Precision Neuroscience is based in New York City, Country.
What sector does Precision Neuroscience operate in?
Precision Neuroscience is tracked under Biotech from New York City, Country, with $180M in disclosed funding.
When did Precision Neuroscience last raise?
The last disclosed Precision Neuroscience round closed in December 2024 at Series C.
Precision Neuroscience totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in New York City below to benchmark round size and investor mix.
